https://peptide.town/story/lilly-q3-earnings-lower-net-pricesPeptide Townen2026-10-30T05:46:00.000ZLilly Q3 earnings show Zepbound and Mounjaro selling more at lower net prices https://peptide.town/story/goodrx-employer-direct-glp-1-pricingPeptide Townen2026-10-30T04:59:00.000ZGoodRx Employer Direct opens GLP 1 drug pricing to all US employers https://peptide.town/story/illinois-glp-1-coverage-state-workersPeptide Townen2026-10-30T04:08:00.000ZIllinois GLP 1 coverage for state workers takes 18 percent of the drug budget https://peptide.town/story/celularity-vesalius-peptide-api-dealPeptide Townen2026-10-30T03:35:00.000ZCelularity Vesalius peptide deal targets compounding pharmacies with no supply date https://peptide.town/story/compounded-tirzepatide-recall-copycat-zepboundPeptide Townen2026-10-30T03:14:00.000ZCompounded tirzepatide recall pulls 22 lots of copycat Zepbound https://peptide.town/story/hhs-peptide-compounding-policy-503a-pharmaciesPeptide Townen2026-10-29T05:43:00.000ZHHS peptide compounding policy lets small pharmacies make six unapproved peptides https://peptide.town/story/glp-1-weight-loss-coverage-no-savingsPeptide Townen2026-10-29T05:12:00.000ZGLP 1 weight loss coverage shrinks as studies find no savings https://peptide.town/story/medicare-glp-1-bridge-skips-part-dPeptide Townen2026-10-29T04:24:00.000ZMedicare GLP 1 Bridge Claims Skip Part D and Start With a Rejection https://peptide.town/story/andel-direct-employer-wegovy-centerwellPeptide Townen2026-10-29T03:29:00.000ZDirect to employer Wegovy comes to Andel as CenterWell Pharmacy joins